42 related articles for article (PubMed ID: 23272952)
1. The Saudi urological association guidelines on urolithiasis.
Kamal W; Azhar RA; Hamri SB; Alathal AH; Alamri A; Alzahrani T; Abeery H; Noureldin YA; Alomar M; Al Own A; Alnazari MM; Alharthi M; Awad MA; Halawani A; Althubiany HH; Alruwaily A; Violette P
Urol Ann; 2024; 16(1):1-27. PubMed ID: 38415236
[TBL] [Abstract][Full Text] [Related]
2. Tissue neutrophil elastase contributes to extracorporeal shock wave lithotripsy-induced kidney damage and the neutrophil elastase inhibitor, sivelestat, attenuates kidney damage with gratifying immunohistopathological and biochemical findings: an experimental study.
Colakerol A; Suzan S; Temiz MZ; Gonultas S; Aykan S; Ozsoy S; Kucuk SH; Yuruk E; Kandırali E; Semercioz A
Urolithiasis; 2022 Feb; 50(1):103-112. PubMed ID: 34778918
[TBL] [Abstract][Full Text] [Related]
3. How to maximize the efficacy of shockwave lithotripsy.
Petrides N; Ismail S; Anjum F; Sriprasad S
Turk J Urol; 2020 Nov; 46(Supp. 1):S19-S26. PubMed ID: 33135997
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of renal point-of-care ultrasound after extracorporeal shock wave lithotripsy.
Magalhães L; Nogué R
Ultrasound J; 2019 Sep; 11(1):25. PubMed ID: 31595354
[TBL] [Abstract][Full Text] [Related]
5. Nephrolithiasis in the Obese Patient.
Kelly C; Geraghty RM; Somani BK
Curr Urol Rep; 2019 May; 20(7):36. PubMed ID: 31104149
[TBL] [Abstract][Full Text] [Related]
6. Indications and contraindications for shock wave lithotripsy and how to improve outcomes.
Reynolds LF; Kroczak T; Pace KT
Asian J Urol; 2018 Oct; 5(4):256-263. PubMed ID: 30364729
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and physiopathology of minor transient shock wave lithotripsy - induced renal injury based on urinary biomarkers levels.
Dzięgała M; Krajewski W; Kołodziej A; Dembowski J; Zdrojowy R
Cent European J Urol; 2018; 71(2):214-220. PubMed ID: 30038813
[TBL] [Abstract][Full Text] [Related]
8. How can and should we optimize extracorporeal shockwave lithotripsy?
Chaussy CG; Tiselius HG
Urolithiasis; 2018 Feb; 46(1):3-17. PubMed ID: 29177561
[TBL] [Abstract][Full Text] [Related]
9. Shockwave lithotripsy: techniques for improving outcomes.
Kroczak T; Scotland KB; Chew B; Pace KT
World J Urol; 2017 Sep; 35(9):1341-1346. PubMed ID: 28608191
[TBL] [Abstract][Full Text] [Related]
10. Hospital admission for treatment of complications after extracorporeal shock wave lithotripsy for renal stones: a study of risk factors.
El-Nahas AR; Taha DE; Elsaadany MM; Zahran MH; Hassan M; Sheir KZ
Urolithiasis; 2018 Jun; 46(3):291-296. PubMed ID: 28555349
[TBL] [Abstract][Full Text] [Related]
11. Successful evacuation of large perirenal hematoma after extracorporeal shock wave lithotripsy (ESWL) - step 1 of the IDEAL recommendations of surgical innovation.
Hallmann S; Petersein J; Ruttloff J; Ecke TH
Clin Case Rep; 2017 Feb; 5(2):123-125. PubMed ID: 28174635
[TBL] [Abstract][Full Text] [Related]
12. Autophagy activation protects shock wave induced renal tubular epithelial cell apoptosis may through modulation of Akt/ GSK-3β pathway.
Long Q; Li X; He H; He D
Int J Biol Sci; 2016; 12(12):1461-1471. PubMed ID: 27994511
[TBL] [Abstract][Full Text] [Related]
13. A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones.
Nussberger F; Roth B; Metzger T; Kiss B; Thalmann GN; Seiler R
Urolithiasis; 2017 Jun; 45(3):317-321. PubMed ID: 27576325
[TBL] [Abstract][Full Text] [Related]
14. Safety and feasibility of day case ureteroscopy and laser lithotripsy (URSL) in patients with a solitary kidney.
Ghosh A; Somani BK
Cent European J Urol; 2016; 69(1):91-5. PubMed ID: 27123333
[TBL] [Abstract][Full Text] [Related]
15. Arguments for choosing extracorporeal shockwave lithotripsy for removal of urinary tract stones.
Tiselius HG; Chaussy CG
Urolithiasis; 2015 Oct; 43(5):387-96. PubMed ID: 26315364
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of renal hematoma: a prospective study of 1,300 SWL treatments.
Schnabel MJ; Gierth M; Chaussy CG; Dötzer K; Burger M; Fritsche HM
Urolithiasis; 2014 Jun; 42(3):247-53. PubMed ID: 24419328
[TBL] [Abstract][Full Text] [Related]
17. Risk factors survey for extracorporeal shockwave lithotripsy-induced renal hematoma.
Lee HY; Yang YH; Shen JT; Jang MY; Shih PM; Wu WJ; Huang CH; Chou YH; Juan YS
J Endourol; 2013 Jun; 27(6):763-7. PubMed ID: 23272952
[TBL] [Abstract][Full Text] [Related]
18. [Renal hematoma after extracorporeal shockwave lithotripsy in a series of 324 consecutive sessions with the DOLI-S lithotripter: incidents, characteristrics, multifactorial analysis and review].
Orozco Fariñas R; Iglesias Prieto JI; Massarrah Halabi J; Mancebo Gómez JM; Perez-Castro Ellendt E
Arch Esp Urol; 2008 Oct; 61(8):889-914. PubMed ID: 19040158
[TBL] [Abstract][Full Text] [Related]
19. A multivariate analysis of risk factors associated with subcapsular hematoma formation following electromagnetic shock wave lithotripsy.
Dhar NB; Thornton J; Karafa MT; Streem SB
J Urol; 2004 Dec; 172(6 Pt 1):2271-4. PubMed ID: 15538247
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
